title: Soy foods and urinary isoprostanes: results from a randomized study in premenopausal women.
abstract: In addition to their antiestrogenic effects, soy isoflavones may protect against cancer through alternate biological actions, for example, antioxidant properties. This randomized crossover study explored the relationship between dietary isoflavone intake through common soy foods and oxidative stress quantified by urinary isoprostane levels. Eighty-two women aged 39.2 ± 6.1 years were randomly selected to receive a high soy diet of 2 soy food servings per day and a low soy diet of <3 servings per week for 6 months each, separated by a 1-month washout period. Urine samples were collected at baseline and at the end of each dietary period. Urinary isoprostane levels were measured using enzyme-linked immunosorbent assays (ELISA) and adjusted for creatinine levels. Mixed models using log-transformed values were applied to evaluate the effect of the high soy diet. Unadjusted isoprostane excretion levels were lower during the high rather than the low soy diet, but this effect was not statistically significant (p = 0.81). After adjustment for urinary creatinine, isoprostane excretion was slightly higher during the high soy diet (p = 0.02), an observation that was confirmed in a regression analysis between urinary isoflavones and isoprostanes during the high soy diet. The original association remained significant when restricted to adherent participants, however this effect disappeared after exclusion of three extreme values. In agreement with several previous reports, these findings do not support the hypothesis that soy exerts antioxidant effects, as measured by urinary isoprostane excretions, but additional markers of oxidative stress need to be investigated in future studies.
authors.affiliation: University of Hawaii Cancer Center, 1236 Lauhala Street, Honolulu, HI 96813, USA.
authors.forename: Cherisse
authors.initials: C
authors.lastname: Sen
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Morimoto
authors.forename: Sreang
authors.initials: S
authors.lastname: Heak
authors.forename: Robert V
authors.initials: RV
authors.lastname: Cooney
authors.forename: Adrian A
authors.initials: AA
authors.lastname: Franke
authors.forename: Gertraud
authors.initials: G
authors.lastname: Maskarinec
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage*; D015415:Biomarkers / Q000652:urine; D003404:Creatinine / Q000652:urine; D018592:Cross-Over Studies; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007529:Isoflavones / Q000378:metabolism* / Q000652:urine; D028421:Isoprostanes / Q000652:urine*; D018384:Oxidative Stress; D010349:Patient Compliance; D017697:Premenopause; D045730:Soy Foods / Q000032:analysis; D011795:Surveys and Questionnaires; D013997:Time Factors
chemical_list: D000975:Antioxidants; D015415:Biomarkers; D007529:Isoflavones; D028421:Isoprostanes; D003404:Creatinine